SCHEMBL16095345

SCHEMBL16095345

CN(CCc1nc(-c2cc(C(=O)O)ccn2)c[nH]1)c1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 11/20 0.44
▸ KDM4A O75164 7/20 0.44
▸ KDM5B Q9UGL1 7/20 0.44
▸ KDM5A P29375 7/20 0.44
▸ KDM5C P41229 5/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ KDM6B O15054 3/20 0.42
▸ KDM2A Q9Y2K7 3/20 0.42
▸ KDM3A Q9Y4C1 3/20 0.42
▸ KMO O15229 1/20 0.41
▸ AURKA O14965 2/20 0.39
▸ JMJD6 Q6NYC1 1/20 0.39
▸ KDM4B O94953 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16095768 0.88 KDM4C (0.44) KDM4CKDM4AKDM5BKDM5AKDM5C
SCHEMBL16095328 0.87 KDM4C (0.43) KDM4CKDM4AKDM5BKDM5AKDM5C
SCHEMBL16094674 0.80 KDM4C (0.48) KDM4CKDM4AKDM5BKDM5AKDM5C
SCHEMBL17604506 0.78 KDM4C (0.54) KDM4CKDM4AKDM5BKDM5AKDM5C
SCHEMBL16095346 0.77 KDM4C (0.52) KDM4CKDM4AKDM5BKDM5AKDM5C
SCHEMBL16095171 0.76 KDM4C (0.60) KDM4CKDM4AKDM5BKDM5AKDM5C
SCHEMBL16033843 0.76 KDM4C (0.76) KDM4CKDM4AKDM5BKDM5A
SCHEMBL16094928 0.76 KDM5C (0.55) KDM4CKDM4AKDM5BKDM5AKDM5C
SCHEMBL16095193 0.75 KDM4C (0.59) KDM4CKDM4AKDM5BKDM5AKDM5C
SCHEMBL16095331 0.74 KDM2B (0.55) KDM4CKDM4AKDM5BKDM5AKDM5C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2969007-A1 HISTONE DEMETHYLASE INHIBITORS Quanticel Pharmaceuticals Inc (US) 2016-01-20 — — EP disclosed
WO-2014151945-A1 HISTONE DEMETHYLASE INHIBITORS Quanticel Pharmaceuticals, Inc. (US) 2014-09-25 — — WO disclosed
Send feedback